Jiangsu Hengrui Pharmaceuticals (600276.SH): Perfluorohexyl octane eye drops approved for market launch

17:03 03/07/2025

Hengrui Medicine Co., Ltd. (600276.SH) issued an announcement that recently, its subsidiary Chengdu Shengdi Medicine Co., Ltd. received...

Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that its subsidiary Chengdu Shengdi Pharmaceutical Co., Ltd. has received notification from the China Food and Drug Administration (CFDA) approving the marketing of the company's product perfluorohexane ophthalmic solution for the treatment of dry eyes related to meibomian gland dysfunction (MGD).

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"